Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$334K Buy
2,777
+852
+44% +$98.4K 0.01% 104
2025
Q4
$203K Buy
+1,925
New +$181K 0.01% 126
2025
Q1
Sell
-2,033
Closed -$202K 120
2024
Q4
$202K Hold
2,033
0.01% 112
2024
Q3
$231K Sell
2,033
-663
-25% -$78.8K 0.01% 112
2024
Q2
$334K Hold
2,696
0.01% 99
2024
Q1
$356K Sell
2,696
-40
-1% -$4.93K 0.01% 98
2023
Q4
$298K Buy
2,736
+40
+1% +$4.15K 0.01% 103
2023
Q3
$278K Buy
2,696
+663
+33% +$71.5K 0.01% 97
2023
Q2
$235K Hold
2,033
0.01% 103
2023
Q1
$216K Sell
2,033
-72
-3% -$7.77K 0.01% 104
2022
Q4
$234K Buy
+2,105
New +$215K 0.01% 98
2019
Q4
Sell
-4,735
Closed -$380K 79
2019
Q3
$380K Hold
4,735
0.04% 58
2019
Q2
$379K Hold
4,735
0.04% 59
2019
Q1
$376K Hold
4,735
0.04% 59
2018
Q4
$345K Sell
4,735
-8
-0.2% -$565 0.04% 58
2018
Q3
$321K Buy
+4,743
New +$302K 0.03% 60

Other funds holding MRK

JMG Financial Group's MRK Position: Q1 2026 in Review

JMG Financial Group increased its Merck (MRK) stake by 44% in Q1 2026, buying an estimated $98.4K and bringing the position to 2,777 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #104.

JMG Financial Group first reported a position in MRK in Q3 2018 and has held it in 16 quarters since. The position peaked at $380K in Q3 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • JMG Financial Group held 2,777 shares of Merck worth $334K as of Q1 2026.
  • JMG Financial Group bought 852 Merck shares in Q1 2026, an estimated $98.4K.
  • Merck made up 0.01% of JMG Financial Group's portfolio in Q1 2026, its #104 holding.
  • JMG Financial Group first reported a position in Merck in Q3 2018 and has held it in 16 quarters since.
  • JMG Financial Group's Merck position peaked at $380K in Q3 2019.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on JMG Financial Group's 13F filing for Q1 2026, filed 7 May 2026.